Tyra Biosciences targets resistance in oncology with purpose built drugs for the benefit of patients.
For more details on financing and valuation for Tyra Biosciences, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
TYRA
13.76 as of 6/1/23
To read this article and more news on Tyra Biosciences, register or login.